糖尿病的管理：同时针对高血糖和氧化应激是否会是更好的万灵药？
Management of diabetes mellitus: could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea?
作者信息
Erejuwa Omotayo O
机构信息
Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
出版信息
Int J Mol Sci. 2012;13(3):2965-2972. doi: 10.3390/ijms13032965. Epub 2012 Mar 6.
Abstract
The primary aim of the current management of diabetes mellitus is to achieve and/or maintain a glycated hemoglobin level of ≤6.5%. However, recent evidence indicates that intensive treatment of hyperglycemia is characterized by increased weight gain, severe hypoglycemia and higher mortality. Besides, evidence suggests that it is difficult to achieve and/or maintain optimal glycemic control in many diabetic patients; and that the benefits of intensively-treated hyperglycemia are restricted to microvascular complications only. In view of these adverse effects and limitations of intensive treatment of hyperglycemia in preventing diabetic complications, which is linked to oxidative stress, this commentary proposes a hypothesis that "simultaneous targeting of hyperglycemia and oxidative stress" could be more effective than "intensive treatment of hyperglycemia" in the management of diabetes mellitus.
摘要
目前糖尿病管理的主要目标是实现和/或维持糖化血红蛋白水平≤6.5%。然而，最近的证据表明，强化血糖治疗的特点是体重增加、严重低血糖和更高的死亡率。此外，有证据表明，许多糖尿病患者难以实现和/或维持最佳血糖控制；而且强化血糖治疗的益处仅局限于微血管并发症。鉴于强化血糖治疗在预防糖尿病并发症方面存在这些不良反应和局限性，且这些并发症与氧化应激有关，本评论提出一个假说，即在糖尿病管理中，“同时针对高血糖和氧化应激”可能比“强化血糖治疗”更有效。
相似文献
1
Management of diabetes mellitus: could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea?糖尿病的管理：同时针对高血糖和氧化应激是否会是更好的万灵药？
Int J Mol Sci. 2012;13(3):2965-2972. doi: 10.3390/ijms13032965. Epub 2012 Mar 6.
2
Glycemic variability: measurement and utility in clinical medicine and research--one viewpoint.血糖变异性：临床医学与研究中的测量及应用——一种观点
Diabetes Technol Ther. 2011 Nov;13(11):1077-80. doi: 10.1089/dia.2011.0104. Epub 2011 Aug 4.
3
Glycemic targets in hospital and barriers to attaining them.医院中的血糖目标及达标障碍。
Can J Diabetes. 2014 Apr;38(2):74-8. doi: 10.1016/j.jcjd.2014.01.001.
4
[Intensive blood glucose reduction: yes or no?].[强化血糖降低：是与否？]
MMW Fortschr Med. 2015 Mar 5;157(4):18-9. doi: 10.1007/s15006-015-2752-8.
5
The "Metabolic Memory" Theory and the Early Treatment of Hyperglycemia in Prevention of Diabetic Complications.“代谢记忆”理论与高血糖的早期治疗对预防糖尿病并发症的作用
Nutrients. 2017 Apr 28;9(5):437. doi: 10.3390/nu9050437.
6
Hyperglycemia and perioperative glucose management.高血糖与围手术期血糖管理。
Curr Pharm Des. 2012;18(38):6195-203. doi: 10.2174/138161212803832236.
7
Glycemic control in the medical intensive care unit.医学重症监护病房中的血糖控制
J Diabetes Sci Technol. 2009 Nov 1;3(6):1330-41. doi: 10.1177/193229680900300613.
8
Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR.糖尿病与心血管疾病：强化血糖控制有益还是致命？来自控制糖尿病患者心血管风险行动（ACCORD）、糖尿病与血管疾病行动（ADVANCE）、退伍军人糖尿病试验（VADT）、英国前瞻性糖尿病研究（UKPDS）、糖尿病预防计划（PROactive）及重症监护病房血糖控制研究（NICE-SUGAR）的经验教训
Wien Med Wochenschr. 2010 Jan;160(1-2):8-19. doi: 10.1007/s10354-010-0748-7.
9
Benefits and harms of intensive glycemic control in patients with type 2 diabetes.2 型糖尿病患者强化血糖控制的获益与危害。
BMJ. 2019 Nov 5;367:l5887. doi: 10.1136/bmj.l5887.
10
Understanding glycemic control in the critically ill: 2011 update.危重症患者的血糖控制：2011年更新版
Hosp Pract (1995). 2011 Apr;39(2):47-55. doi: 10.3810/hp.2011.04.394.
引用本文的文献
1
Possible Involvement of Vitamin C in Periodontal Disease-Diabetes Mellitus Association.维生素 C 可能与牙周病-糖尿病的关系有关。
Nutrients. 2020 Feb 20;12(2):553. doi: 10.3390/nu12020553.
2
Combined Effects of Curcumin and Lycopene or Bixin in Yoghurt on Inhibition of LDL Oxidation and Increases in HDL and Paraoxonase Levels in Streptozotocin-Diabetic Rats.姜黄素与番茄红素或胭脂树橙联合添加于酸奶中对链脲佐菌素诱导的糖尿病大鼠低密度脂蛋白氧化的抑制作用及高密度脂蛋白和对氧磷酶水平升高的影响。
Int J Mol Sci. 2017 Mar 23;18(4):332. doi: 10.3390/ijms18040332.
3
The use of probiotic L. fermentum ME-3 containing Reg'Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study.使用含Reg'Activ Cholesterol补充剂的益生菌发酵乳杆菌ME-3四周对血液脂蛋白谱和炎性细胞因子有积极影响：一项开放标签的初步研究。
Nutr J. 2016 Oct 28;15(1):93. doi: 10.1186/s12937-016-0213-6.
4
Alteration in Inflammation-related miR-146a Expression in NF-KB Signaling Pathway in Diabetic Rat Hippocampus.糖尿病大鼠海马中NF-κB信号通路中炎症相关miR-146a表达的改变
Adv Pharm Bull. 2016 Mar;6(1):99-103. doi: 10.15171/apb.2016.015. Epub 2016 Mar 17.
5
Beneficial effects of a red wine polyphenol extract on high-fat diet-induced metabolic syndrome in rats.红酒多酚提取物对高脂饮食诱导的大鼠代谢综合征的有益作用。
Eur J Nutr. 2017 Jun;56(4):1467-1475. doi: 10.1007/s00394-016-1192-2. Epub 2016 Feb 25.
6
Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model.硬化蛋白抗体治疗可改善I型糖尿病小鼠模型的骨折预后。
Bone. 2016 Jan;82:122-34. doi: 10.1016/j.bone.2015.04.048. Epub 2015 May 5.
7
Effect of honey in diabetes mellitus: matters arising.蜂蜜对糖尿病的影响：相关问题
J Diabetes Metab Disord. 2014 Jan 29;13(1):23. doi: 10.1186/2251-6581-13-23.
8
Antihyperglycemic and antihyperlipidemic activities of aqueous extract of Hericium erinaceus in experimental diabetic rats.糙皮侧耳水提物对实验性糖尿病大鼠的降血糖和降血脂作用。
BMC Complement Altern Med. 2013 Oct 3;13:253. doi: 10.1186/1472-6882-13-253.
9
Honey--a novel antidiabetic agent.蜂蜜——一种新型的抗糖尿病药物。
Int J Biol Sci. 2012;8(6):913-34. doi: 10.7150/ijbs.3697. Epub 2012 Jul 7.
10
Honey: a novel antioxidant.蜂蜜：一种新型抗氧化剂。
Molecules. 2012 Apr 12;17(4):4400-23. doi: 10.3390/molecules17044400.
本文引用的文献
1
Inadequate diabetic care: global figures cry for preventive measures and personalized treatment.糖尿病护理不足：全球数据呼吁采取预防措施和个性化治疗。
EPMA J. 2010 Mar;1(1):13-8. doi: 10.1007/s13167-010-0006-5. Epub 2010 Mar 23.
2
Honey supplementation in spontaneously hypertensive rats elicits antihypertensive effect via amelioration of renal oxidative stress.蜂蜜补充剂可通过改善自发性高血压大鼠的肾脏氧化应激来发挥降压作用。
Oxid Med Cell Longev. 2012;2012:374037. doi: 10.1155/2012/374037. Epub 2012 Jan 23.
3
IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.国际糖尿病联盟糖尿病地图集：2011 年和 2030 年全球糖尿病患病率估计。
Diabetes Res Clin Pract. 2011 Dec;94(3):311-21. doi: 10.1016/j.diabres.2011.10.029. Epub 2011 Nov 12.
4
Death during intensive glycemic therapy of diabetes: mechanisms and implications.糖尿病强化血糖治疗期间的死亡：机制与影响
Am J Med. 2011 Nov;124(11):993-6. doi: 10.1016/j.amjmed.2011.08.008.
5
Differential responses to blood pressure and oxidative stress in streptozotocin-induced diabetic Wistar-Kyoto rats and spontaneously hypertensive rats: effects of antioxidant (honey) treatment.链脲佐菌素诱导的糖尿病Wistar-Kyoto大鼠和自发性高血压大鼠对血压和氧化应激的不同反应：抗氧化剂（蜂蜜）治疗的效果
Int J Mol Sci. 2011;12(3):1888-907. doi: 10.3390/ijms12031888. Epub 2011 Mar 16.
6
Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats.格列本脲或二甲双胍联合蜂蜜可改善链脲佐菌素诱导的糖尿病大鼠的血糖控制。
Int J Biol Sci. 2011 Mar 14;7(2):244-52. doi: 10.7150/ijbs.7.244.
7
Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats.蜂蜜、格列本脲、二甲双胍及其组合对链脲佐菌素诱导的糖尿病大鼠肾脏抗氧化作用的比较。
Int J Mol Sci. 2011 Jan 21;12(1):829-43. doi: 10.3390/ijms12010829.
8
Diagnosis and classification of diabetes mellitus.糖尿病的诊断与分类
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S62-9. doi: 10.2337/dc11-S062.
9
Oxidative stress and diabetic complications.氧化应激与糖尿病并发症。
Circ Res. 2010 Oct 29;107(9):1058-70. doi: 10.1161/CIRCRESAHA.110.223545.
10
Intestinal oxidative state can alter nutrient and drug bioavailability.肠道氧化状态可改变营养素和药物的生物利用度。
Oxid Med Cell Longev. 2009 Nov-Dec;2(5):322-7. doi: 10.4161/oxim.2.5.9769.
Zotero 插件